Bioavailability Is a Spec, Not a Claim

2000%. That is the number behind BioPerine® — 20x higher curcumin bioavailability versus plain curcumin in human subjects (Shoba & Majeed, Planta Medica, 1998). It is a measured ratio against a named reference, in people, in print.

Now read the back of most labels: "enhanced absorption," "superior bioavailability," "maximum uptake." No ratio. No reference compound. No study. Those are claims. A number with a comparator and a citation is a spec. The difference is the whole game, and it is the difference your QA reviewer, your regulator, and your repeat customer will eventually find.

Bioavailability is the fraction of an ingested dose that reaches systemic circulation in an active form. For most botanicals the raw fraction is low — curcumin alone is poorly absorbed, rapidly metabolised, and quickly cleared. Dosing more does not fix this; past a point, more unabsorbed material just passes through.

So absorption gets engineered. There are three mechanisms worth knowing, because each carries a different kind of receipt — and each has a tradeoff you should be able to name out loud.

BioPerine® is standardised piperine from black pepper. It does not make curcumin more soluble. It slows the liver and gut enzymes that would otherwise conjugate and clear the compound — so more of the same dose stays in circulation, longer.

The receipt: 2000% higher curcumin bioavailability, Shoba & Majeed, Planta Medica 1998. The tradeoff: piperine is a broad enzyme modulator. The same mechanism that holds curcumin in plasma can affect how other actives are cleared. That is a formulation conversation to have early, not a footnote to bury.

Meriva® is a Curcumin Phytosome® — curcuminoids bound to phosphatidylcholine so the complex crosses the gut wall as a lipid, not a stubborn pigment. The structure is the delivery system.

The receipt: 29x higher curcuminoid absorption versus standard curcumin (Cuomo et al., 2011). The tradeoff: the phospholipid carrier is mass. A Phytosome® serving weighs more per unit of active, so your capsule count or fill volume goes up. You are paying in pill size and cost-per-dose to buy a measured 29x — an honest trade, as long as you state it.

Ferrochel® is ferrous bisglycinate — iron chelated to two glycine molecules. The amino-acid cage protects the iron through the gut, reduces the free-iron reactions that cause the metallic taste and GI upset of cheaper salts, and presents it for absorption via amino-acid pathways.

The receipt: 4.7x higher iron absorption versus ferrous sulfate (American Journal of Clinical Nutrition, 2000). The tradeoff: chelated minerals cost more per milligram of elemental iron than ferrous sulfate, and the elemental load per gram is lower. You buy tolerability and a 4.7x absorption ratio — the cost is the proof you chose absorption over the cheapest input.

Demand four things, every time. One: a ratio, not an adjective — a number like 29x or 2000%. Two: a named reference — "versus standard curcumin," "versus ferrous sulfate" — because a multiplier without a baseline is theatre. Three: the study — author, journal, year, and ideally the design (in vitro, animal, or human; human plasma data outranks a dissolution-beaker test). Four: the branded, licensed active by name, so the data attaches to the exact material in your formula, not a generic cousin.

If any of the four is missing, treat the claim as unverified until proven. "Clinically studied form" with no citation is a sentence, not evidence.

The study was run on BioPerine®, on Meriva®, on Ferrochel® — specific, characterised, batch-controlled materials from named licensors. The data is not transferable to an unbranded piperine, an unspecified "curcumin phospholipid," or a generic bisglycinate. That is why we name the branded active and keep the ®/™, and why we never write "proprietary blend" — a blend that hides ratios hides the one thing absorption depends on.

Insignis Bioscience is the contract-manufacturing arm of Nuvea Essentials, formulating private-label across India, the UAE, Saudi Arabia, the USA, Sri Lanka, Singapore, Nepal, and Myanmar. We hold the licensor documentation and put the ratio, the reference, and the citation on the spec sheet. It is harder than printing "high absorption," and slower, and it costs more per dose. That cost is the point — it is the part a buyer can verify.

Bioavailability supports the rest of your formula doing its job — but only the version you can document. Engineer it with a known mechanism, source it as a named active, and write it as a ratio against a reference with a study behind it.

Bring us the actives you want and the markets you ship to. We will return a formulation where every absorption number on the label has its receipt in the same breath — or we will tell you the claim cannot be supported and why. Either way, you ship a spec, not a slogan.